The EQ-5D and the EuroQol Group

Lloyd AJ & Pickard SA. (2019). Value in Health, 22(1), 21-22.

Read More

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

Brazier J, Ara R, Azzabi I ... Lloyd AJ, Paisley MA & Pickard SA. (2019). Value in Health, 22(3), 267-275.

Read More

Patient reported outcome and observer reported outcome assessment in rare disease trials

Acaster, S. (2017) Value in Health, 20(7)

Read More

A novel patient-derived conceptual model of the impact of coeliac disease in adults: Implications for patient-reported outcome and health-related quality of life instrument development

Leffler D, Acaster S, Gallop K, Dennis M, Adelman D. (2017) Value in Health

Read More

Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment

Lloyd AJ, Gallop K, Ali S, Hughes D & MacCulloch A. (2017) Current medical research and opinion, 33(1), 23-29

Read More

EQ-5D: Moving from Three Levels to Five

Lloyd AJ Value Health 2018 21, 57–58

Read More

Special Edition on Utility Measurement

Lloyd, AJ PharmacoEconomics (2017). 35(Suppl 1): 5

Read More